These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 28348153)

  • 1. Clofazimine-Containing Regimen for the Treatment of Mycobacterium abscessus Lung Disease.
    Yang B; Jhun BW; Moon SM; Lee H; Park HY; Jeon K; Kim DH; Kim SY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28348153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics and Treatment Outcomes of Patients with Acquired Macrolide-Resistant Mycobacterium abscessus Lung Disease.
    Choi H; Kim SY; Kim DH; Huh HJ; Ki CS; Lee NY; Lee SH; Shin S; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful antibiotic treatment of pulmonary disease caused by Mycobacterium abscessus subsp. abscessus with C-to-T mutation at position 19 in erm(41) gene: case report.
    Kim SY; Shin SJ; Jeong BH; Koh WJ
    BMC Infect Dis; 2016 May; 16():207. PubMed ID: 27188784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus.
    Koh WJ; Jeon K; Lee NY; Kim BJ; Kook YH; Lee SH; Park YK; Kim CK; Shin SJ; Huitt GA; Daley CL; Kwon OJ
    Am J Respir Crit Care Med; 2011 Feb; 183(3):405-10. PubMed ID: 20833823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Inhaled Amikacin-Containing Multidrug Regimens for Mycobacterium abscessus Pulmonary Disease.
    Kang N; Jeon K; Kim H; Kwon OJ; Huh HJ; Lee NY; Daley CL; Koh WJ; Jhun BW
    Chest; 2021 Aug; 160(2):436-445. PubMed ID: 33621600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin.
    Ferro BE; Meletiadis J; Wattenberg M; de Jong A; van Soolingen D; Mouton JW; van Ingen J
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1097-105. PubMed ID: 26643335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense.
    Park J; Cho J; Lee CH; Han SK; Yim JJ
    Clin Infect Dis; 2017 Feb; 64(3):301-308. PubMed ID: 28011609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease.
    Lyu J; Kim BJ; Kim BJ; Song JW; Choi CM; Oh YM; Lee SD; Kim WS; Kim DS; Shim TS
    Respir Med; 2014 Nov; 108(11):1706-12. PubMed ID: 25245792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterial Characteristics and Treatment Outcomes in Mycobacterium abscessus Lung Disease.
    Koh WJ; Jeong BH; Kim SY; Jeon K; Park KU; Jhun BW; Lee H; Park HY; Kim DH; Huh HJ; Ki CS; Lee NY; Kim HK; Choi YS; Kim J; Lee SH; Kim CK; Shin SJ; Daley CL; Kim H; Kwon OJ
    Clin Infect Dis; 2017 Feb; 64(3):309-316. PubMed ID: 28011608
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Luo J; Yu X; Jiang G; Fu Y; Huo F; Ma Y; Wang F; Shang Y; Liang Q; Xue Y; Huang H
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Review and Meta-analyses of the Effect of Chemotherapy on Pulmonary Mycobacterium abscessus Outcomes and Disease Recurrence.
    Pasipanodya JG; Ogbonna D; Ferro BE; Magombedze G; Srivastava S; Deshpande D; Gumbo T
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial CT findings of Mycobacterium massiliense pulmonary disease compared with Mycobacterium abscessus disease after treatment with antibiotic therapy.
    Kim HS; Lee KS; Koh WJ; Jeon K; Lee EJ; Kang H; Ahn J
    Radiology; 2012 Apr; 263(1):260-70. PubMed ID: 22371609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The TetR Family Transcription Factor MAB_2299c Regulates the Expression of Two Distinct MmpS-MmpL Efflux Pumps Involved in Cross-Resistance to Clofazimine and Bedaquiline in Mycobacterium abscessus.
    Gutiérrez AV; Richard M; Roquet-Banères F; Viljoen A; Kremer L
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332077
    [No Abstract]   [Full Text] [Related]  

  • 14. Clofazimine in
    Pinapala A; Koh LJ; Ng KH; Tambyah PA; Yap HK
    Perit Dial Int; 2021 Jan; 41(1):104-109. PubMed ID: 32148178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients.
    Jeon K; Kwon OJ; Lee NY; Kim BJ; Kook YH; Lee SH; Park YK; Kim CK; Koh WJ
    Am J Respir Crit Care Med; 2009 Nov; 180(9):896-902. PubMed ID: 19661243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal Inhibitory Concentration of Clofazimine Among Clinical Isolates of Nontuberculous Mycobacteria and Its Impact on Treatment Outcome.
    Kwak N; Whang J; Yang JS; Kim TS; Kim SA; Yim JJ
    Chest; 2021 Feb; 159(2):517-523. PubMed ID: 32712225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Mutations Associated with Clofazimine Resistance in Mycobacterium abscessus.
    Chen Y; Chen J; Zhang S; Shi W; Zhang W; Zhu M; Zhang Y
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712660
    [No Abstract]   [Full Text] [Related]  

  • 18. Vancomycin and Clarithromycin Show Synergy against
    Mukherjee D; Wu ML; Teo JWP; Dick T
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clofazimine for the treatment of multidrug-resistant tuberculosis: prospective, multicenter, randomized controlled study in China.
    Tang S; Yao L; Hao X; Liu Y; Zeng L; Liu G; Li M; Li F; Wu M; Zhu Y; Sun H; Gu J; Wang X; Zhang Z
    Clin Infect Dis; 2015 May; 60(9):1361-7. PubMed ID: 25605283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series.
    Namkoong H; Morimoto K; Nishimura T; Tanaka H; Sugiura H; Yamada Y; Kurosaki A; Asakura T; Suzuki S; Fujiwara H; Yagi K; Ishii M; Tasaka S; Betsuyaku T; Hoshino Y; Kurashima A; Hasegawa N
    BMC Infect Dis; 2016 Aug; 16():396. PubMed ID: 27506679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.